PTGS2 and neoplasm: Broad inhibition of PGE2 signaling pathways with NSAIDs that block both COX-1 and COX-2 (e.g., naproxen), or those that block only COX-2 (e.g., celecoxib), results in antitumor effects in mouse syngeneic tumor models.